APEN - Apollo Endosurgery, Inc.
| Previous Close | 5.8500 |
| Open | 5.8100 |
| Bid | 4.8000 x 100 |
| Ask | 7.4500 x 300 |
| Day's Range | 5.8100 - 5.8617 |
| 52 Week Range | 3.5500 - 11.8800 |
| Volume | 3,166 |
| Avg. Volume | 27,787 |
| Market Cap | 101.146M |
| Beta | 0.24 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.0120 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.13 |
- Business Wire•17 hours ago
Apollo Endosurgery Announces Approval of the New 12-month Weight Loss Balloon - ORBERA365™ - in the Kingdom of Saudi Arabia
Apollo Endosurgery, Inc. (“Apollo”) (APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that the Saudi Food and Drug Authority (SFDA) has approved the ORBERA365™ Managed Weight Loss System and has issued a Medical Device Marketing Authorization (MDMA) for the product. This MDMA allows Apollo Endosurgery to market ORBERA365 in the Kingdom of Saudi Arabia with its exclusive distribution partner, AL-Nozha Medical. The ORBERA365 Managed Weight Loss System doubles the indwell period of the #1 intragastric balloon in the world from 6 months to a 12 month treatment period.
- GlobeNewswire•25 days ago
Analysis: Positioning to Benefit within Aerojet Rocketdyne, Summit Hotel Properties, Apollo Endosurgery, The KEYW Holding, FARO Technologies, and Tilly's — Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, March 30, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
- Business Wire•last month
Apollo Endosurgery Announces Conclusion of LAP-BAND® Low BMI Post-Approval Study
Apollo Endosurgery, Inc. , a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that the FDA has approved the termination of the LAP-BAND® Lower Body Mass Index Post-approval study .
- ACCESSWIRE•2 months ago
Blog Exposure - FDA Approves First Automated Robotic Movement in technIQ(TM) Series for Corindus’ CorPath GRX Platform
Stock Monitor: Apollo Endosurgery Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 07, 2018 / Active-Investors.com has just released a free research report on Corindus Vascular Robotics, Inc. (NYSE: ...
- Business Wire•2 months ago
Apollo Endosurgery, Inc. to Participate at the 30th Annual ROTH Conference
Apollo Endosurgery, Inc. , a leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today that Company management is scheduled to present at the 30th Annual ROTH Conference being held March 11-14, 2018 at the Ritz-Carlton Laguna Niguel in Orange County, CA.
- Business Wire•2 months ago
Apollo Endosurgery, Inc. Reports Fourth Quarter and Full Year 2017 Results
Apollo Endosurgery, Inc. , a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced financial results for the fourth quarter and year ended December 31, 2017.
- Business Wire•2 months ago
Apollo Endosurgery Announces First ORBERA® U.S. Post-Approval Publication
Apollo Endosurgery, Inc. , a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced the first ORBERA® U.S.
- Business Wire•2 months ago
Apollo Endosurgery Announces MFDS Approval for the ORBERA® Intragastric Balloon System in South Korea, a Non-Surgical Solution to Assist Patients with Weight Loss
Apollo Endosurgery, Inc. , a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced the South Korean Ministry of Food and Drug Safety’s approval of the ORBERA® Intragastric Balloon System, the #1 intragastric balloon in the world, to assist adult patients who are overweight – with a body mass index greater than 27 - in losing and maintaining weight....
- Business Wire•2 months ago
Apollo Endosurgery, Inc. to Report Fourth Quarter and Full Year 2017 Results on March 1, 2018
Apollo Endosurgery, Inc. , a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that it plans to release its financial results for the fourth quarter and full year ended December 31, 2017 on Thursday, March 1, 2018, after the U.S.
- GlobeNewswire•3 months ago
Market Trends Toward New Normal in Cornerstone Strategic Return Fund, Acacia Communications, PennantPark Floating Rate Capital, Floor & Decor, Liberty Media, and Apollo Endosurgery — Emerging Consolidated Expectations, Analyst Ratings
NEW YORK, Jan. 31, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Cornerstone ...
- Zacks•5 months ago
The Zacks Analyst Blog Highlights: BioLife Solutions, SeaSpine Holdings, Apollo Endosurgery and CareDx
The Zacks Analyst Blog Highlights: BioLife Solutions, SeaSpine Holdings, Apollo Endosurgery and CareDx
- SmarterAnalyst•5 months ago
Apollo Endosurgery Inc (APEN) Sparks Optimism Among Investors; Here’s Why
The medical device maker announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a special gastroscope and an innovative suturing device called OverStitch. Apollo Endosurgery shares reacted to the news, jumping nearly 45% to $5.88, as of this writing. APEN has a 1-year high of $21.88 and a 1-year low of $2.93. Apollo CEO Christopher Gostout commented, "Endoscopic suturing is quickly becoming a global standard of care for a variety of endoscopic procedures backed by a growing level of clinical evidence.
- Business Wire•5 months ago
Apollo Endosurgery Receives FDA Clearance for OverStitch™ Sx Endoscopic Suturing System
Apollo Endosurgery, Inc. , a leader in less invasive surgical medical devices for bariatric and gastrointestinal procedures, announced today U.S. Food and Drug Administration 510k clearance of the OverStitch Sx, a new, full-thickness flexible endoscopic suturing system that will work on a broad range of single-channel flexible endoscopes.
- Business Wire•5 months ago
Apollo Endosurgery to Present at the 29th Annual Piper Jaffray Healthcare Conference
Apollo Endosurgery, Inc. , a leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today that Company management is scheduled to present at the 29th Annual Piper Jaffray Healthcare Conference on November 28, 2017 at 8:50 am ET in New York, NY.
- Business Wire•5 months ago
David C. Pacitti Joins Apollo Endosurgery Board of Directors
The Board of Directors of Apollo Endosurgery, Inc. , today announced the appointment of David C. Pacitti as an independent director of Apollo. He will commence service on December 8, 2017.
- Business Wire•6 months ago
Apollo Endosurgery Announces Presentation of the Brazilian Intragastric Balloon Consensus Statement at ObesityWeek
Apollo Endosurgery, Inc. , a leader in less invasive surgical medical devices for bariatric and gastrointestinal procedures, announced the presentation of the largest global review of intragastric balloons titled “Brazilian Intragastric Balloon Consensus after more than 40,000 cases” at ObesityWeek 2017 – the combined annual meetings for both American Society for Metabolic & Bariatric Surgery and The ...
- Business Wire•6 months ago
Apollo Endosurgery, Inc. Reports Third Quarter 2017 Results
Apollo Endosurgery, Inc. , a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced financial results for the third quarter ended September 30, 2017.
- Business Wire•6 months ago
Apollo Endosurgery and American Gastroenterological Association to Establish Endoscopic Suturing Procedure Registry
Apollo Endosurgery, Inc. , a leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today it has entered into a Registry Funding Agreement with the American Gastroenterological Association Center for GI Innovation and Technology to develop and administer a registry to evaluate flexible endoscopic procedures enabled by the OverStitch™ Endoscopic Suturing System....
- Business Wire•6 months ago
Apollo Endosurgery to Report Third Quarter 2017 Financial Results on October 26, 2017
Apollo Endosurgery, Inc. , a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that it plans to release its third quarter 2017 financial results on Thursday, October 26, 2017 after the U.S.
- Business Wire•7 months ago
Apollo Endosurgery to Present at the Cantor Fitzgerald Global Healthcare Conference
Apollo Endosurgery, Inc. , a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that company management is scheduled to present at the Cantor Fitzgerald Global Healthcare Conference on Tuesday, September 26 at 9:10 am Eastern in New York, NY.
- Business Wire•8 months ago
Apollo Endosurgery Announces 20-year LAP-BAND® Outcomes Data Presented at 22nd IFSO World Congress in London
Apollo Endosurgery, Inc. , a leader in less invasive surgical medical devices for bariatric and gastrointestinal procedures, announced the presentation of 20 year outcomes data for the LAP-BAND® System today at the 22nd World Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders in London.
- Business Wire•8 months ago
Apollo Endosurgery Announces CE Mark Approval for the ORBERA365™ Managed Weight Loss System, Expanding the Indwell Period from 6 Months to 12 Months with the Gastric Balloon Category Leader
Apollo Endosurgery, Inc. , a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced CE Mark approval for the ORBERA365 Managed Weight Loss System.
- Business Wire•8 months ago
Apollo Endosurgery Provides Update and Clarity to FDA Letter to Health Care Providers Related to Potential Risks of Intragastric Balloons
Apollo Endosurgery, Inc. , a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today provided an update and clarifications to a letter the U.S.
- Business Wire•9 months ago
Apollo Endosurgery, Inc. Reports Second Quarter 2017 Results
Apollo Endosurgery, Inc. , a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced financial results for the second quarter ended June 30, 2017.
